BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18325775)

  • 1. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.
    Reed T; Perluigi M; Sultana R; Pierce WM; Klein JB; Turner DM; Coccia R; Markesbery WR; Butterfield DA
    Neurobiol Dis; 2008 Apr; 30(1):107-20. PubMed ID: 18325775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.
    Reed TT; Pierce WM; Markesbery WR; Butterfield DA
    Brain Res; 2009 Jun; 1274():66-76. PubMed ID: 19374891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
    Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
    Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease.
    Williams TI; Lynn BC; Markesbery WR; Lovell MA
    Neurobiol Aging; 2006 Aug; 27(8):1094-9. PubMed ID: 15993986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
    Sultana R; Perluigi M; Newman SF; Pierce WM; Cini C; Coccia R; Butterfield DA
    Antioxid Redox Signal; 2010 Mar; 12(3):327-36. PubMed ID: 19686046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
    Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
    Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
    Butterfield DA; Bader Lange ML; Sultana R
    Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.
    Opii WO; Joshi G; Head E; Milgram NW; Muggenburg BA; Klein JB; Pierce WM; Cotman CW; Butterfield DA
    Neurobiol Aging; 2008 Jan; 29(1):51-70. PubMed ID: 17055614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal.
    Ethen CM; Reilly C; Feng X; Olsen TW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3469-79. PubMed ID: 17652714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD.
    Sultana R; Boyd-Kimball D; Poon HF; Cai J; Pierce WM; Klein JB; Merchant M; Markesbery WR; Butterfield DA
    Neurobiol Aging; 2006 Nov; 27(11):1564-76. PubMed ID: 16271804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71.
    Castegna A; Aksenov M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    J Neurochem; 2002 Sep; 82(6):1524-32. PubMed ID: 12354300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
    Sultana R; Reed T; Perluigi M; Coccia R; Pierce WM; Butterfield DA
    J Cell Mol Med; 2007; 11(4):839-51. PubMed ID: 17760844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
    Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
    Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
    Di Domenico F; Tramutola A; Butterfield DA
    Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.